Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement

Abstract

Whereas FDA-approved methods of assessment of estrogen receptor (ER) are ‘fit for purpose’, they represent a 30-year-old technology. New quantitative methods, both chromogenic and fluorescent, have been developed and studies have shown that these methods increase the accuracy of assessment of ER. Here, we compare three methods of ER detection and assessment… (More)
DOI: 10.1038/labinvest.2016.73

Topics

  • Presentations referencing similar topics